Medical Device News Magazine

Centinel Spine® to Host Major Worldwide Live Surgery Broadcast in Two-Day Meeting on Lumbar Disc Arthroplasty featuring prodisc® L Total Disc Replacement

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Centinel Spine®, LLC, (“the Company”) a leading global medical device company addressing cervical and lumbar spinal disease by providing the most robust and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), will host a major global two-day virtual meeting on lumbar disc arthroplasty featuring the prodisc L TDR as part of the Company’s med+ Medical Education program. This med+ event is presented by the spine surgery faculty of CCV Montpellier and Clinique du Parc, the home of the prodisc technology as invented by Dr. Thierry Marnay. The two-day hybrid event will take place at CCV Montpellier-Castelnau-le-Lez, France and over a live interactive video stream from May 25-26.

This event follows closely upon the nomination of prodisc for the Prix Galien award, which honors innovators in life sciences and medical device technology and is widely regarded as the equivalent of the Nobel Prize for the life sciences industry. The Galien nomination recognizes more than 35 years of work by Dr. Marnay in developing and advancing disc replacement techniques for both the cervical spine and lumbar spine. Studies involving thousands of patients have confirmed long-term efficacy and safety (up to 21 years of follow-up).

“The restoration of mobility is a huge advance in spinal surgery,” said Dr. Marnay, further noting, “This course will continue the tradition of providing surgeons around the world with pearls in arthroplasty techniques for efficiently managing patients with degenerative disc disease.”

Participants will review basic and advanced techniques and surgical treatment options for patients with lumbar degenerative disc disease, using the prodisc L TDR, via anterior access of the lumbar spine. The course format includes live observation and broadcast of a variety of indications for lumbar TDR, interspersed with brief lectures and case discussions with expert spine faculty. The worldwide event is intended for both spine and anterior access surgeons.

Esteemed CCV Montpellier faculty includes Dr. Guilhaume Geneste, Dr. Grégory Edgard-Rosa, Dr. Martin Grau Ortiz, Dr. Caroline Hirsch, and Dr. Thierry Marnay. In-person participants will rotate into a surgery for direct observation of techniques, while viewing the remaining cases and all lectures through a live-surgery broadcast. Virtual participants can elect to observe all or any part of the proceedings via a video stream with chat capabilities, accessed through a unique link obtained upon registration.

According to Dr. Grégory Edgard-Rosa, “The upcoming lumbar disc arthroplasty with prodisc L total disc replacement course is a wonderful opportunity for surgeons to learn from the birthplace of modern lumbar disc arthroplasty in the way that they learn best—a combination of lectures, case reviews, and live surgery.”

“Surgeon education is one of our top priorities,” said Centinel Spine CEO Steve Murray. “Our Medical Education program allows surgeons to deepen their knowledge and training by examining the unique anatomy of individuals and gaining an understanding of how our varied prodisc anatomical implant options can be best used to maintain a patient’s mobility.”

To register and learn more about the event, please visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”